Robbins Farley LLC Pfizer Inc Transaction History

Robbins Farley LLC

$196 Million
Q3 2024

A detailed history of Robbins Farley LLC transactions in Pfizer Inc stock. As of the latest transaction made, Robbins Farley LLC holds 721 shares of PFE stock, worth $18,118. This represents 0.01% of its overall portfolio holdings.

Number of Shares

721

Previous 1,014 28.9%

Holding current value

$18,118

Previous $28,000 28.57%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$27.7 - $31.39 $8,116 - $9,197	-293 Reduced 28.9%	721 $20,000
Q2 2024 Jul 16, 2024	SELL	$25.26 - $29.6 $3,763 - $4,410	-149 Reduced 12.81%	1,014 $28,000
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $12,001 - $14,028	-374 Reduced 24.33%	1,163 $38,000
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $18,060 - $20,895	500 Added 48.22%	1,537 $56,000
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $1,811 - $2,358	-46 Reduced 4.25%	1,037 $42,000
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $772,458 - $1.01 Million	-18,502 Reduced 94.47%	1,083 $55,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $2.31 Million - $2.82 Million	-52,808 Reduced 72.95%	19,585 $857,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $7,258 - $8,606	-156 Reduced 0.22%	72,393 $3.8 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $3.32 Million - $4.11 Million	72,549 New	72,549 $3.76 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $4.05 Million - $6.01 Million	-98,108 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $231,575 - $297,478	5,900 Added 6.4%	98,108 $4.22 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $1.09 Million - $1.24 Million	-30,437 Reduced 24.82%	92,208 $3.61 Million
Q4 2020 Mar 04, 2021	BUY	$33.47 - $42.56 $4.1 Million - $5.22 Million	122,645 New	122,645 $4.52 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robbins Farley LLC with notifications on news.

Account

Robbins Farley LLC Pfizer Inc Transaction History